Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

Perspective

Big Marijuana — Lessons from Big Tobacco

List of authors.
  • Kimber P. Richter, Ph.D., M.P.H.,
  • and Sharon Levy, M.D., M.P.H.

The tobacco industry has unfortunately provided a detailed road map for marijuana: deny addiction potential, downplay adverse health effects, create as large a market as possible, and protect it through lobbying, campaign contributions, and other advocacy efforts.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

This article was published on June 11, 2014, at NEJM.org.

Author Affiliations

From the Department of Preventive Medicine and Public Health, University of Kansas Medical Center, and the University of Kansas Cancer Center — both in Kansas City (K.P.R.); and the Division of Developmental Medicine and Adolescent Substance Abuse Program, Boston Children's Hospital, and Harvard Medical School — both in Boston (S.L.).

Print Subscriber? Activate your online access.